sunbet

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
ÓªÑøÐÔÖ¬·¾¸ÎÄ£×Ó
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > Ïû»¯ÏµÍ³Ä£×Ó > ÓªÑøÐÔÖ¬·¾¸ÎÄ£×Ó

ǰÑÔ

Ö¬·¾¸Î(fatty liver disease,FLD)ÊÇÖ¸ÓÉÓÚÖÖÖÖÔµ¹ÊÔ­ÓÉÒýÆðµÄ¸ÎÔàÖ¬·¾´úлÕϰ­ £¬Ö¬ÀàÎïÖʵĶ¯Ì¬Æ½ºâʧµ÷ £¬¸Îϸ°ûÄÚÖ¬·¾Èº¼¯¹ý¶àµÄ²¡±ä¡£Ö¬·¾¸ÎµÄ·¢²¡ÂʽüÄêÀ´Ñ¸ËÙÉÏÉý £¬ÒѳÉΪ½ö´ÎÓÚ²¡¶¾ÐÔ¸ÎÑ׵ĵڶþ´ó¸Î²¡ £¬ÕýÑÏÖØÍþв¹úÈ˵Ŀµ½¡¡£Æ¾Ö¤²¡Òò £¬Ö¬·¾¸Î¿É·ÖΪ·Ç¾Æ¾«ÐԺ;ƾ«ÐÔÁ½´óÀà¡£·Ç¾Æ¾«ÐÔÖ¬·¾ÐԸβ¡(nonalcoholic fatty liver disease, NAFLD)·¢²¡»úÖÆÏÖÔÚÉÐδÃ÷È· £¬ÖÎÁÆÉÏҲȱ·¦ÓÐÓò½·¥ £¬ÊÇÏÖÔÚÑо¿µÄÖØµã¡£¾Æ¾«ÐÔÖ¬·¾¸Î¶¯ÎïÄ£×ÓÒÔÒûʳÓÕµ¼ÎªÖ÷ £¬¾Æ¾«¿Éʹ¶¯Îï¸ÎÔàÑõÏûºÄÂÊÔö¸ß £¬ÔöÌíѪñ¼ÑªµÄÑõÏûºÄ £¬´Ó¶øïÔÌ­¶ÔСҶÖÐÐĸÎϸ°ûµÄÑõ¹© £¬ÒýÆð¸ÃÇøÓòµÄ¸Îϸ°ûÍË»¯Ó뻵ËÀ £¬²¢±¬·¢Ö¬·¾±äÐÔ¡£ÀíÏëµÄÖ¬·¾¸Î¶¯ÎïÄ£×ÓÓ¦ÓëÈËÀàÖ¬·¾ÐԸβ¡µÄÌØÕ÷ÏàËÆ £¬¼´²¡±äÉú³¤Àú³ÌÓÐÏà¶ÔÏÔ×ŵķ֯Ú £¬´Ó´¿´âÐÔÖ¬·¾¸Î¡¢Ö¬·¾ÐÔ¸ÎÑס¢¸ÎÏËά»¯ÖÁ¸ÎÓ²»¯ £¬²¢ÇÒÓ¦¾ßÓÐÄ£×ÓÐγÉÂʸߡ¢éæÃüÂʵ͡¢ÔìÄ£ÒªÁìÇáÓ¯Ò×ÐС¢¶ÔʵÑéÖ°Ô±ÎÞº¦¡¢ÔìÄ£×èÖ¹ºó²¡±äÄæ×ª»ºÂý £¬±ãÓÚ¾ÙÐÐÒ©Îï¸ÉÔ¤ÊÔÑéµÈÌØµã¡£ÏÖÔÚÒѾ­ÔÚ´óÊó¡¢É³Êó¡¢Ð¡Êó¡¢¼ÒÍúÍÖíµÈ¶¯ÎïÖÖÊôÀֳɵؽ¨ÉèÁËÖ¬·¾¸Î¶¯ÎïÄ£×Ó £¬ÕâЩ¶¯ÎïÄ£×ÓΪÃ÷È·Ö¬·¾¸Î·¢²¡»úÖÆ¡¢É¸Ñ¡Ò©ÎïµÈ»ù´¡ºÍÁÙ´²Ñо¿ÌṩÁ˺ܺõÄʵÑ鹤¾ß¡£

FLD¶¯ÎïÄ£×ÓÖ÷Òª·ÖΪËÄ´óÀࣺ×Ô¾õÐÔÄ£×Ó £¬»ùÒòÐÞÊζ¯ÎïÄ£×Ó £¬Òûʳ¡¢Ò©Îï»ò¶¾ÎïÓÕµ¼Ä£×Ó £¬¸´ºÏÄ£×Ó£¨ÍŽáÓ¦ÓûùÒòÄ£×ÓºÍÓªÑøÄ£×Ó£©¡£ËüÃÇÔÚ²î±ðµÄ²ãÃæÊ©Õ¹×÷Óà £¬µ«×îÖÕÖ÷ÒªÊÇͨ¹ýʹ¸ÎÔàÖ¬·¾ÊäÈ루ºÏ³É»òÉãÈ룩ÔöÌí»òÊä³ö£¨É¨³ý£©ïÔÌ­µÄÔ­ÀíÖÆ³É¡£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯Î´óÊó¡¢Ð¡Êó

¡¾ÔìÄ£ÒªÁì¡¿£º

µ¨¼îµ°°±Ëáȱ·¦(methionine­choline-deficient,MCD)Òûʳ³£ÓÃÀ´ÓÕµ¼¾­µäµÄNAFLD¶¯ÎïÄ£×Ó¡£MCDÒûʳ¸»º¬Ì¼Ë®»¯ºÏÎï(40%)ºÍÖ¬·¾(10%£© £¬µ«È±·¦¼ÓÈë¸Îϸ°ûÖ¬·¾ËáβÑõ»¯ºÍºÏ³É¼«µÍÃܶÈÖ¬ÂѰ׵ĵ°°±ËáºÍµ¨¼î £¬ÓÃÓÚÎ¹ÑøµÄÄö³ÝÀදÎï £¬Èç´óÊóºÍСÊó¡£

¸ßÖ¬Òûʳ(high fat diet,HFD)Ä£×Ó£ºÊ¹ÓÃHFD£¨Ì¼Ë®»¯ºÏÎï¡¢Ö¬·¾¡¢ÂѰ×ÖÊ»®·ÖÕ¼×ÜÈÈ×îµÄ52%¡¢30£¥ºÍ18%£©ËÇÑø´óÊó¡¢ëàÊó¡¢¼ÒÍá¢È®µÈ¾ù¿ÉÓÕ·¢NAFLD¡£

ȫ賦ÍâÓªÑø(total parenteral nutrition,TPN)Ä£×Ó£º³ÉÄê´óÊóÉî¾²Âö£¨ÈçÉÏÇ»¾²Âö£©²å¹Ü £¬ÅþÁ¬ÊäÒº±Ã½«·ÇÂѰ×ÓªÑøÒº£¨Èç¸ßÆÏÌÑÌǼӰ±»ùËáµÄ¸ßÓªÑøÒºÌå»òÆÏÌÑÌǼÓÖ¬·¾È飩һÁ¬µÎ×¢¡£

Tsukamato-French´óÊóÄ£×Ó£º1984Äê £¬Tsukamato­FrenchµÈ¸ø´óÊóÊÖÊõÖ²Èëθ¹Ü £¬Ò»Á¬×¢È뺬ÒÒ´¼µÄÒºÌåʳÁÏά³Ö´óÊóѪÖÐ200~300mg/dlµÄÒÒ´¼Å¨¶È £¬ÔìÄ£3¸öÔ £¬»òͬʱÒÔÈÈÁ¿Àο¿ £¬º¬ÉÙÁ¿ÓñÃ×ÓÍ(4.9£¥ÈÈÁ¿£©ÒºÌåʳÁÏÒ»Á¬Î¸¹ÜËÇÑø30Ìì¡£

ÒÒ´¼¹àθģ×Ó£ºÔÚÎ¹Ñø¹ÌÌåËÇÁϵÄͬʱÖðÈÕÒÒ´¼¹àθ(11~12g/kg)´óÊó4ÖÜ £¬Ò²¿Éµ¼ÖÂÓëTsukamato-FrenchÒªÁìÏàËÆµÄ¸Î×é֯ѧ²¡±ä¡£Óø߶Ȱ׾Æ(6¡æ×óÓÒ£©ÖðÈÕ¹àθһ´Î(5ml/100g) £¬¸øÓèÓªÑøÈ±·¦ËÇÁÏ£¨Ãæ·Û¡¢´Î·Û¡¢²Ý·Û¡¢¶¹·Û £¬°´2 : 1 : 1 : 1 ±ÈÀýÅä·½ £¬Áí¼ÓÉÙÁ¿¶¹Óͼ°Ê³ÑΣ© £¬ÓÚÿÍí½ûʳÖÁÔ½ÈÕÉÏÎç¿Õ¸¹¹àθºóÔÙιËÇÁÏ £¬Ò»Á¬75Ìì¼´¿É±¬·¢¾Æ¾«ÐÔÖ¬·¾¸Î¡£¹àθÒà¿ÉʹÓð׾ơ¢ÓñÃ×ÓÍ¡¢ßÁßò»ìÏýÒº£¨°×¾Æ8~12g/kg £¬ÓñÃ×2g/kg £¬ßÁßò24mg/kg), Ôìģʱ¼äΪ12ÖÜ¡£

¡¾Ä£×ÓÌØµã¡¿£º

MCDÄ£×Ó£ºÇáÓ¯Ò×ÐÐ £¬µ«·¢²¡¼°ÆäˮƽÓëÊóµÄÐÔ±ð¡¢Æ·Ïµ¡¢ÖÖÀàÓйØ £¬ËÇÑøÐ¡Êó1~2Öܼ´ÓÐÏÔ×ŵĸÎÖ¬·¾±ä £¬2Öܺ󱬷¢¸ÎÔ໵ËÀÐÔÑ×Ö¢¼Ì¶ø·ºÆðñ¼ÖܺÍÖÐÑë¾²ÂöÖÜΧÏËά»¯ £¬°éѪÇåת°±Ã¸ÏÔÖøÉý¸ßºÍ¸ÎÔàÄÚÖ¬ÖÊÑõ»¯Ã¸»ùÒò±í´ïÉϵ÷£»ÒûʳËÇÑøSprague Dawley´óÊóÔòÏ£ÍûÂý £¬ÔÚÔìÄ£2ÖÜ·ºÆð¸ÎÖ¬·¾±äºÍÑõ»¯Ó¦¼¤ £¬5ÖÜʱ·ºÆð¸ÎÔàÑ×Ö¢»µËÀ°éת°±Ã¸Çá¶ÈÉý¸ß £¬12ÖÜ·ºÆð¸ÎÏËά»¯¡£MCDÒûʳιËÇÊó¼¡ÈâºÍÇûÌåÖ¬·¾º¬Á¿ïÔÌ­°éÌåÖØÏ½µ £¬ÔìÄ£4ÖܺóÍâÖÜ×éÖ¯¶ÔÒȵºËØÃô¸Ð¿É·ºÆðµÍѪÌÇ¡£

HFDÄ£×Ó£ºÔìÄ£4ÖÜ·ºÆðÉ¢ÔÚÐÔ¸ÎÖ¬·¾±ä £¬8ÖÜ·ºÆð´¿´âÐÔÖ¬·¾¸Î £¬12ÖÜΪ֬·¾ÐÔ¸ÎÑ× £¬16ÖܸÎÔàÑ×Ö¢»µËÀˮƽ¼Ó¾ç°éñ¼ÖÜÏËά»¯ £¬24ÖÜÖ¬·¾±äºÍÑ×Ö¢ÂÔ¼õÇá £¬µ«ÏËά»¯¼Ó¾ç £¬ÉõÖÁ·ºÆð¾àÀëÏËά»¯¡£´óÊ󸹲¿ÄÚÔàÖ¬·¾Ôö¶à £¬ÍâÖÜѪÓÎÀëÖ¬·¾ËáºÍ×ܵ¨¹Ì´¼¾ÙÐÐÐÔÉý¸ß £¬°éÞ²ÂöÄÚ¶¾ËØÑªÖ¢¡¢¸Îϸ°ûÏßÁ£ÌåËðÉË¡¢ÑõÓ¦¼¤Ö¬ÖʹýÑõ»¯ËðÉËÒÔ¼°¸ÎÔà¿â ÆÕ¸¥Ï¸°û¼¤»îµÈÕ÷Ïó £¬²¢ÇÒÓÐÒȵºËضԿ¹ £¬µ«ÌåÖØºÍѪҺTGÔöÌí²»ÏÔ×Å £¬

TPNÄ£×Ó£ºµ±ÓªÑøÒºÖзÇÂѰ×ÄÜÁ¿Õ¼33£¥ÒÔÉÏ»ò×ÜÉãÈëÁ¿Õ¼×ÜÈÈÁ¿µÄ83£¥ÒÔÉÏʱ £¬1Öܺó´óÊó¸ÎÔ༴ÓÐÏÔ×ŵÄÖ¬·¾±äÐÔ¡£ÈôʹÓÃ¸ßÆÏÌÑÌǺͰ±»ùËáµÄ¸ßÓªÑøÒºÌåÔöÌíÖÁËùÐè·ÇÂѰ×ÖÊÄÜÁ¿µÄ146%£ÛÏ൱ÓÚ350·ÇÂѰ×ÖÊ¿¨/(kg·d)£ÝºÍ335% µªÐèÒªÁ¿£ÛÏ൱ÓÚ2.7g°±»ùËᵪ/(kg·d) ],1/2Ìì¼´·ºÆð¸Î´ó £¬2Ììºó¸ÎÌÇÔ­¡¢Ö¬·¾Ôö¶à¡£ÖÁµÚ4Ìì¸ÎÔàÖ¬·¾ÔöÌí4±¶ £¬Åãͬ¸ÎÄÚ±ØÐèÖ¬·¾Ëáȱ·¦Öð½¥¼ÓÖØ¡£

ÒÒ´¼¹àθģ×Ó£º¶¯ÎïÌåÖØÔöÌí»ºÂý £¬ÒûʳÁ¿ÏÔ×ÅϽµ £¬´ó²¿·Ö¶¯Îï»á·ºÆð´ó±ãäçй¡£²¡Àí×é֯ѧ¿É¼û¸Îϸ°ûË®Ö× £¬³ÊÆøÇòÑù±ä £¬°ûÖÊÄÚÆÕ±é·ºÆð¾Þϸ²»µÈµÄÔ²ÐÎÖ¬·¾µÎ £¬²¢¿É¼ûÊÈËáÐÔ¹æÔò»ò²»¹æÔòСÌåÐγÉ £¬¼´ÒÒ´¼ÐÔ²£Á§Ð¡Ìå¡£»ã¹ÜÇøÑ×֢ϸ°û½þÈóÏÔ×Å £¬²¢¿É¼û½ºÔ­ÏËάÔöÉú £¬¸Îñ¼ÄÚÆ¤Ï¸°ûÖ×ÕÍ¡£

 

²Î¿¼ÎÄÏ×£º

1.Ê©ÐÂé࣮ÏÖ´úҽѧʵÑ鶯Îïѧ£®±±¾©£ºÈËÃñ¾üÒ½³öÊéÉç £¬2000

2.Farrell GC, van Rooyen D. Liver cholesterol: is ii playing possum in NASH? Am J Physiol Gastroinlesl Liver Physiol,2012,303 (1):G9-11

3.Maher JJ. New insights from rodent models of fatly liver disease. Anliox.id Redox Signal, 2011, 15 (2):535-550

4.Matsuzawa N,Takamura T, Kurita S, el al. Lipid-induced oxidative stress causes sleatohepalitis in, mice fed an atherogenic diet. Hepatology, 2007,46 (5):1392-1403

5.Sahai A, Malladi P, Pan X, el al. Obese and diabeti db/db mice develop marked liver fibrosis  in a  model of nonalcoholic steatohepalitis: role of sbortform leptin receptors and osteopontin. Am J Physiol Gastroinlest Liver Pbysiol, 2004,287 (5):Gl035-1043

6.Uno M, Kurita S, Misu H,et al. Tranilast,an anlifibrogenic agent, ameliorates a dietary rat model of nonalcoholic steatohepalitis. Hepatology, 2008, 48 (1) : 109-118

7.Xu Z,Chen L,Leung L,el al. Liver-specific i.naclivalion of the Nrfl gene in adult mouse leads lo nonalcoholic steatobepatilis and hepatic neoplasia. Proc Natl Acad Sci US A, 2005, 15; 102 (11):4120-4125

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Ä£×ÓĿ¼
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > Ïû»¯ÏµÍ³Ä£×Ó > ÓªÑøÐÔÖ¬·¾¸ÎÄ£×Ó
ÓªÑøÐÔÖ¬·¾¸ÎÄ£×Ó

ǰÑÔ

Ö¬·¾¸Î(fatty liver disease,FLD)ÊÇÖ¸ÓÉÓÚÖÖÖÖÔµ¹ÊÔ­ÓÉÒýÆðµÄ¸ÎÔàÖ¬·¾´úлÕϰ­ £¬Ö¬ÀàÎïÖʵĶ¯Ì¬Æ½ºâʧµ÷ £¬¸Îϸ°ûÄÚÖ¬·¾Èº¼¯¹ý¶àµÄ²¡±ä¡£Ö¬·¾¸ÎµÄ·¢²¡ÂʽüÄêÀ´Ñ¸ËÙÉÏÉý £¬ÒѳÉΪ½ö´ÎÓÚ²¡¶¾ÐÔ¸ÎÑ׵ĵڶþ´ó¸Î²¡ £¬ÕýÑÏÖØÍþв¹úÈ˵Ŀµ½¡¡£Æ¾Ö¤²¡Òò £¬Ö¬·¾¸Î¿É·ÖΪ·Ç¾Æ¾«ÐԺ;ƾ«ÐÔÁ½´óÀà¡£·Ç¾Æ¾«ÐÔÖ¬·¾ÐԸβ¡(nonalcoholic fatty liver disease, NAFLD)·¢²¡»úÖÆÏÖÔÚÉÐδÃ÷È· £¬ÖÎÁÆÉÏҲȱ·¦ÓÐÓò½·¥ £¬ÊÇÏÖÔÚÑо¿µÄÖØµã¡£¾Æ¾«ÐÔÖ¬·¾¸Î¶¯ÎïÄ£×ÓÒÔÒûʳÓÕµ¼ÎªÖ÷ £¬¾Æ¾«¿Éʹ¶¯Îï¸ÎÔàÑõÏûºÄÂÊÔö¸ß £¬ÔöÌíѪñ¼ÑªµÄÑõÏûºÄ £¬´Ó¶øïÔÌ­¶ÔСҶÖÐÐĸÎϸ°ûµÄÑõ¹© £¬ÒýÆð¸ÃÇøÓòµÄ¸Îϸ°ûÍË»¯Ó뻵ËÀ £¬²¢±¬·¢Ö¬·¾±äÐÔ¡£ÀíÏëµÄÖ¬·¾¸Î¶¯ÎïÄ£×ÓÓ¦ÓëÈËÀàÖ¬·¾ÐԸβ¡µÄÌØÕ÷ÏàËÆ £¬¼´²¡±äÉú³¤Àú³ÌÓÐÏà¶ÔÏÔ×ŵķ֯Ú £¬´Ó´¿´âÐÔÖ¬·¾¸Î¡¢Ö¬·¾ÐÔ¸ÎÑס¢¸ÎÏËά»¯ÖÁ¸ÎÓ²»¯ £¬²¢ÇÒÓ¦¾ßÓÐÄ£×ÓÐγÉÂʸߡ¢éæÃüÂʵ͡¢ÔìÄ£ÒªÁìÇáÓ¯Ò×ÐС¢¶ÔʵÑéÖ°Ô±ÎÞº¦¡¢ÔìÄ£×èÖ¹ºó²¡±äÄæ×ª»ºÂý £¬±ãÓÚ¾ÙÐÐÒ©Îï¸ÉÔ¤ÊÔÑéµÈÌØµã¡£ÏÖÔÚÒѾ­ÔÚ´óÊó¡¢É³Êó¡¢Ð¡Êó¡¢¼ÒÍúÍÖíµÈ¶¯ÎïÖÖÊôÀֳɵؽ¨ÉèÁËÖ¬·¾¸Î¶¯ÎïÄ£×Ó £¬ÕâЩ¶¯ÎïÄ£×ÓΪÃ÷È·Ö¬·¾¸Î·¢²¡»úÖÆ¡¢É¸Ñ¡Ò©ÎïµÈ»ù´¡ºÍÁÙ´²Ñо¿ÌṩÁ˺ܺõÄʵÑ鹤¾ß¡£

FLD¶¯ÎïÄ£×ÓÖ÷Òª·ÖΪËÄ´óÀࣺ×Ô¾õÐÔÄ£×Ó £¬»ùÒòÐÞÊζ¯ÎïÄ£×Ó £¬Òûʳ¡¢Ò©Îï»ò¶¾ÎïÓÕµ¼Ä£×Ó £¬¸´ºÏÄ£×Ó£¨ÍŽáÓ¦ÓûùÒòÄ£×ÓºÍÓªÑøÄ£×Ó£©¡£ËüÃÇÔÚ²î±ðµÄ²ãÃæÊ©Õ¹×÷Óà £¬µ«×îÖÕÖ÷ÒªÊÇͨ¹ýʹ¸ÎÔàÖ¬·¾ÊäÈ루ºÏ³É»òÉãÈ룩ÔöÌí»òÊä³ö£¨É¨³ý£©ïÔÌ­µÄÔ­ÀíÖÆ³É¡£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯Î´óÊó¡¢Ð¡Êó

¡¾ÔìÄ£ÒªÁì¡¿£º

µ¨¼îµ°°±Ëáȱ·¦(methionine­choline-deficient,MCD)Òûʳ³£ÓÃÀ´ÓÕµ¼¾­µäµÄNAFLD¶¯ÎïÄ£×Ó¡£MCDÒûʳ¸»º¬Ì¼Ë®»¯ºÏÎï(40%)ºÍÖ¬·¾(10%£© £¬µ«È±·¦¼ÓÈë¸Îϸ°ûÖ¬·¾ËáβÑõ»¯ºÍºÏ³É¼«µÍÃܶÈÖ¬ÂѰ׵ĵ°°±ËáºÍµ¨¼î £¬ÓÃÓÚÎ¹ÑøµÄÄö³ÝÀදÎï £¬Èç´óÊóºÍСÊó¡£

¸ßÖ¬Òûʳ(high fat diet,HFD)Ä£×Ó£ºÊ¹ÓÃHFD£¨Ì¼Ë®»¯ºÏÎï¡¢Ö¬·¾¡¢ÂѰ×ÖÊ»®·ÖÕ¼×ÜÈÈ×îµÄ52%¡¢30£¥ºÍ18%£©ËÇÑø´óÊó¡¢ëàÊó¡¢¼ÒÍá¢È®µÈ¾ù¿ÉÓÕ·¢NAFLD¡£

ȫ賦ÍâÓªÑø(total parenteral nutrition,TPN)Ä£×Ó£º³ÉÄê´óÊóÉî¾²Âö£¨ÈçÉÏÇ»¾²Âö£©²å¹Ü £¬ÅþÁ¬ÊäÒº±Ã½«·ÇÂѰ×ÓªÑøÒº£¨Èç¸ßÆÏÌÑÌǼӰ±»ùËáµÄ¸ßÓªÑøÒºÌå»òÆÏÌÑÌǼÓÖ¬·¾È飩һÁ¬µÎ×¢¡£

Tsukamato-French´óÊóÄ£×Ó£º1984Äê £¬Tsukamato­FrenchµÈ¸ø´óÊóÊÖÊõÖ²Èëθ¹Ü £¬Ò»Á¬×¢È뺬ÒÒ´¼µÄÒºÌåʳÁÏά³Ö´óÊóѪÖÐ200~300mg/dlµÄÒÒ´¼Å¨¶È £¬ÔìÄ£3¸öÔ £¬»òͬʱÒÔÈÈÁ¿Àο¿ £¬º¬ÉÙÁ¿ÓñÃ×ÓÍ(4.9£¥ÈÈÁ¿£©ÒºÌåʳÁÏÒ»Á¬Î¸¹ÜËÇÑø30Ìì¡£

ÒÒ´¼¹àθģ×Ó£ºÔÚÎ¹Ñø¹ÌÌåËÇÁϵÄͬʱÖðÈÕÒÒ´¼¹àθ(11~12g/kg)´óÊó4ÖÜ £¬Ò²¿Éµ¼ÖÂÓëTsukamato-FrenchÒªÁìÏàËÆµÄ¸Î×é֯ѧ²¡±ä¡£Óø߶Ȱ׾Æ(6¡æ×óÓÒ£©ÖðÈÕ¹àθһ´Î(5ml/100g) £¬¸øÓèÓªÑøÈ±·¦ËÇÁÏ£¨Ãæ·Û¡¢´Î·Û¡¢²Ý·Û¡¢¶¹·Û £¬°´2 : 1 : 1 : 1 ±ÈÀýÅä·½ £¬Áí¼ÓÉÙÁ¿¶¹Óͼ°Ê³ÑΣ© £¬ÓÚÿÍí½ûʳÖÁÔ½ÈÕÉÏÎç¿Õ¸¹¹àθºóÔÙιËÇÁÏ £¬Ò»Á¬75Ìì¼´¿É±¬·¢¾Æ¾«ÐÔÖ¬·¾¸Î¡£¹àθÒà¿ÉʹÓð׾ơ¢ÓñÃ×ÓÍ¡¢ßÁßò»ìÏýÒº£¨°×¾Æ8~12g/kg £¬ÓñÃ×2g/kg £¬ßÁßò24mg/kg), Ôìģʱ¼äΪ12ÖÜ¡£

¡¾Ä£×ÓÌØµã¡¿£º

MCDÄ£×Ó£ºÇáÓ¯Ò×ÐÐ £¬µ«·¢²¡¼°ÆäˮƽÓëÊóµÄÐÔ±ð¡¢Æ·Ïµ¡¢ÖÖÀàÓйØ £¬ËÇÑøÐ¡Êó1~2Öܼ´ÓÐÏÔ×ŵĸÎÖ¬·¾±ä £¬2Öܺ󱬷¢¸ÎÔ໵ËÀÐÔÑ×Ö¢¼Ì¶ø·ºÆðñ¼ÖܺÍÖÐÑë¾²ÂöÖÜΧÏËά»¯ £¬°éѪÇåת°±Ã¸ÏÔÖøÉý¸ßºÍ¸ÎÔàÄÚÖ¬ÖÊÑõ»¯Ã¸»ùÒò±í´ïÉϵ÷£»ÒûʳËÇÑøSprague Dawley´óÊóÔòÏ£ÍûÂý £¬ÔÚÔìÄ£2ÖÜ·ºÆð¸ÎÖ¬·¾±äºÍÑõ»¯Ó¦¼¤ £¬5ÖÜʱ·ºÆð¸ÎÔàÑ×Ö¢»µËÀ°éת°±Ã¸Çá¶ÈÉý¸ß £¬12ÖÜ·ºÆð¸ÎÏËά»¯¡£MCDÒûʳιËÇÊó¼¡ÈâºÍÇûÌåÖ¬·¾º¬Á¿ïÔÌ­°éÌåÖØÏ½µ £¬ÔìÄ£4ÖܺóÍâÖÜ×éÖ¯¶ÔÒȵºËØÃô¸Ð¿É·ºÆðµÍѪÌÇ¡£

HFDÄ£×Ó£ºÔìÄ£4ÖÜ·ºÆðÉ¢ÔÚÐÔ¸ÎÖ¬·¾±ä £¬8ÖÜ·ºÆð´¿´âÐÔÖ¬·¾¸Î £¬12ÖÜΪ֬·¾ÐÔ¸ÎÑ× £¬16ÖܸÎÔàÑ×Ö¢»µËÀˮƽ¼Ó¾ç°éñ¼ÖÜÏËά»¯ £¬24ÖÜÖ¬·¾±äºÍÑ×Ö¢ÂÔ¼õÇá £¬µ«ÏËά»¯¼Ó¾ç £¬ÉõÖÁ·ºÆð¾àÀëÏËά»¯¡£´óÊ󸹲¿ÄÚÔàÖ¬·¾Ôö¶à £¬ÍâÖÜѪÓÎÀëÖ¬·¾ËáºÍ×ܵ¨¹Ì´¼¾ÙÐÐÐÔÉý¸ß £¬°éÞ²ÂöÄÚ¶¾ËØÑªÖ¢¡¢¸Îϸ°ûÏßÁ£ÌåËðÉË¡¢ÑõÓ¦¼¤Ö¬ÖʹýÑõ»¯ËðÉËÒÔ¼°¸ÎÔà¿â ÆÕ¸¥Ï¸°û¼¤»îµÈÕ÷Ïó £¬²¢ÇÒÓÐÒȵºËضԿ¹ £¬µ«ÌåÖØºÍѪҺTGÔöÌí²»ÏÔ×Å £¬

TPNÄ£×Ó£ºµ±ÓªÑøÒºÖзÇÂѰ×ÄÜÁ¿Õ¼33£¥ÒÔÉÏ»ò×ÜÉãÈëÁ¿Õ¼×ÜÈÈÁ¿µÄ83£¥ÒÔÉÏʱ £¬1Öܺó´óÊó¸ÎÔ༴ÓÐÏÔ×ŵÄÖ¬·¾±äÐÔ¡£ÈôʹÓÃ¸ßÆÏÌÑÌǺͰ±»ùËáµÄ¸ßÓªÑøÒºÌåÔöÌíÖÁËùÐè·ÇÂѰ×ÖÊÄÜÁ¿µÄ146%£ÛÏ൱ÓÚ350·ÇÂѰ×ÖÊ¿¨/(kg·d)£ÝºÍ335% µªÐèÒªÁ¿£ÛÏ൱ÓÚ2.7g°±»ùËᵪ/(kg·d) ],1/2Ìì¼´·ºÆð¸Î´ó £¬2Ììºó¸ÎÌÇÔ­¡¢Ö¬·¾Ôö¶à¡£ÖÁµÚ4Ìì¸ÎÔàÖ¬·¾ÔöÌí4±¶ £¬Åãͬ¸ÎÄÚ±ØÐèÖ¬·¾Ëáȱ·¦Öð½¥¼ÓÖØ¡£

ÒÒ´¼¹àθģ×Ó£º¶¯ÎïÌåÖØÔöÌí»ºÂý £¬ÒûʳÁ¿ÏÔ×ÅϽµ £¬´ó²¿·Ö¶¯Îï»á·ºÆð´ó±ãäçй¡£²¡Àí×é֯ѧ¿É¼û¸Îϸ°ûË®Ö× £¬³ÊÆøÇòÑù±ä £¬°ûÖÊÄÚÆÕ±é·ºÆð¾Þϸ²»µÈµÄÔ²ÐÎÖ¬·¾µÎ £¬²¢¿É¼ûÊÈËáÐÔ¹æÔò»ò²»¹æÔòСÌåÐγÉ £¬¼´ÒÒ´¼ÐÔ²£Á§Ð¡Ìå¡£»ã¹ÜÇøÑ×֢ϸ°û½þÈóÏÔ×Å £¬²¢¿É¼û½ºÔ­ÏËάÔöÉú £¬¸Îñ¼ÄÚÆ¤Ï¸°ûÖ×ÕÍ¡£

 

²Î¿¼ÎÄÏ×£º

1.Ê©ÐÂé࣮ÏÖ´úҽѧʵÑ鶯Îïѧ£®±±¾©£ºÈËÃñ¾üÒ½³öÊéÉç £¬2000

2.Farrell GC, van Rooyen D. Liver cholesterol: is ii playing possum in NASH? Am J Physiol Gastroinlesl Liver Physiol,2012,303 (1):G9-11

3.Maher JJ. New insights from rodent models of fatly liver disease. Anliox.id Redox Signal, 2011, 15 (2):535-550

4.Matsuzawa N,Takamura T, Kurita S, el al. Lipid-induced oxidative stress causes sleatohepalitis in, mice fed an atherogenic diet. Hepatology, 2007,46 (5):1392-1403

5.Sahai A, Malladi P, Pan X, el al. Obese and diabeti db/db mice develop marked liver fibrosis  in a  model of nonalcoholic steatohepalitis: role of sbortform leptin receptors and osteopontin. Am J Physiol Gastroinlest Liver Pbysiol, 2004,287 (5):Gl035-1043

6.Uno M, Kurita S, Misu H,et al. Tranilast,an anlifibrogenic agent, ameliorates a dietary rat model of nonalcoholic steatohepalitis. Hepatology, 2008, 48 (1) : 109-118

7.Xu Z,Chen L,Leung L,el al. Liver-specific i.naclivalion of the Nrfl gene in adult mouse leads lo nonalcoholic steatobepatilis and hepatic neoplasia. Proc Natl Acad Sci US A, 2005, 15; 102 (11):4120-4125

¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿